logo
15:49 Jun 23

Nectar Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
11.51
-0.31 (-2.62%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Nectar Lifesciences Ltd. Financials

Nectar Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
11.51
-0.31 (-2.62%)
15:49 Jun 23
Quality
image/svg+xml

39/100
Medium Financial Strength

Valuation
image/svg+xml

28/100
Expensive Valuation

Technical

28/100
Technically Bearish

Strength

4

Weakness

11

Opportunity

1

Threats

0

-50.29 %

ROE %

-47.11 %

ROA %

-13.06

EPS

29.97

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
1668.83 1523.67 1684.09 1669.97 0
Operating Expenses +
1510.29 1470.66 1532.53 1699.53 60.7
Raw Material
1207.32 1200.84 1242.45 1250.72 0
Increase Decrease in Cost
15.81 -41.55 -40.21 117.29 0
Other Manufacturing Expense
146.37 172.14 184.64 163.22 0
Employee Cost
74.55 77.78 84.67 96.48 1.91
Miscellaneous Expenses
67.12 61.45 60.98 71.82 58.79
Operating Profit
158.54 53.01 151.56 -29.56 -60.7
Other Income
11.32 43.18 14.58 4.99 9.29
Depreciation
56.97 59.12 60.72 62.39 0.34
Interest
78.81 79.49 87.14 74.58 36.13
Profit before tax and exceptio..
34.08 -42.42 18.27 -161.53 -87.88
Exceptional Items
0 0 0 0 0
PBT
34.08 -42.42 18.27 -161.53 -87.88
Provision for Taxation
9.03 -18.24 13.27 -47.85 -30.53
Net Profit
25.05 -24.18 5 -113.68 -292.89
NET Profit after MI
25.05 -24.18 5 -113.68 -292.89
EPS
1.12 -1.08 0.22 -5.07 -13.4
Operating Profit Margin (%)
9.5 3.48 9 -1.77 0
Net Profit Margin (%)
1.5 -1.59 0.3 -6.81 0

Nectar Lifesciences Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: